These dying cells promoted antitumor immunity by inducing DC (dendritic cells) maturation, cross-priming and proliferation of CD8+ T cells and NK cells in vitro and in vivo and successfully created an antitumor vaccine effect in different tumor mice models [261,262,263,264]. The gene discussed is CD8A; the disease is neoplasm.